Lacrimal gland dosimetry for the brain imaging agent technetium-99m-HMPAO

Javier Villanueva-Meyer, D. Thompson, I. Mena, C. S. Marcus

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

We calculated lacrimal gland dosimetry for the brain imaging agent 99mTc-HMPAO. One hundred thirty-eight patients were studied using a dedicated brain imaging device. Only 11% of the patients showed lacrimal gland uptake. For a 740-MBq (20 mCi) injected dose of 99mTc-HMPAO, the radiation exposure to the lacrimal glands is 10.2 mGy (1.02 rad), or 0.0138 mGy/MBq (0.051 rad/mCi). These values are five times lower than the ones reported by the manufacturer of HMPAO. As the dosimetry calculation is only for subjects showing 99mTc-HMPAO uptake in the lacrimal gland, the average radiation dose to all subjects is considerably lower, 1/10 of the estimated value.

Original languageEnglish (US)
Pages (from-to)1237-1239
Number of pages3
JournalJournal of Nuclear Medicine
Volume31
Issue number7
StatePublished - Jan 1 1990
Externally publishedYes

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Lacrimal gland dosimetry for the brain imaging agent technetium-99m-HMPAO'. Together they form a unique fingerprint.

  • Cite this

    Villanueva-Meyer, J., Thompson, D., Mena, I., & Marcus, C. S. (1990). Lacrimal gland dosimetry for the brain imaging agent technetium-99m-HMPAO. Journal of Nuclear Medicine, 31(7), 1237-1239.